Szyman Catherine M.

CIK 00014385385 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001438538

Recent Transactions

50 trades

Award
MASIMO CORP$MASI
Restricted Stock Units
2026-03-06+39,904→ 39,904 total
Exercise/Conversion
MASIMO CORP$MASI
Common Stock
2026-02-12$132.96/sh+11,141→ 11,141 total
Tax Payment
MASIMO CORP$MASI
Common Stock
2026-02-12−4,568→ 6,573 total
Exercise/Conversion
MASIMO CORP$MASI
Restricted Stock Units
2026-02-12−11,141→ 22,283 total
Award
MASIMO CORP$MASI
Non-Qualified Stock Option (Right to Buy)
2025-03-11+18,617→ 18,617 total
Award
MASIMO CORP$MASI
Restricted Stock Units
2025-03-11+8,407→ 8,407 total
Disposition from Tender
Inari Medical, Inc.
Common Stock
2025-02-19−22,429→ 0 total
Disposition to Issuer
Inari Medical, Inc.
Stock Option
2025-02-19−49,719→ 0 total
Award
MASIMO CORP$MASI
Restricted Stock Units
2025-02-12+33,424→ 33,424 total
Tax Payment
Edwards Lifesciences Corp$EW
Common Stock
2024-09-03$69.96/sh−5,530→ 81,287.437 total
Award
Edwards Lifesciences Corp$EW
Common Stock
2024-09-03+10,910→ 86,817.437 total
Tax Payment
Edwards Lifesciences Corp$EW
Common Stock
2024-07-07$92.32/sh−258→ 75,907.437 total
Tax Payment
Edwards Lifesciences Corp$EW
Common Stock
2024-05-11$86.72/sh−827→ 76,165.437 total
Award
Edwards Lifesciences Corp$EW
Common Stock
2024-05-07+32,025→ 77,601.437 total
Tax Payment
Edwards Lifesciences Corp$EW
Common Stock
2024-05-07$85.09/sh−609→ 76,992.437 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Performance Rights
2024-05-04−5,796→ 0 total
Tax Payment
Edwards Lifesciences Corp$EW
Common Stock
2024-05-04$85.25/sh−3,442→ 45,576.437 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2024-05-04+5,796→ 49,018.437 total
Tax Payment
Edwards Lifesciences Corp$EW
Common Stock
2024-05-03$85.06/sh−479→ 43,222.437 total
Award
Inari Medical, Inc.
Common Stock
2024-04-24$42.41/sh+4,126→ 22,429 total
Award
Inari Medical, Inc.
Common Stock
2024-04-24$42.41/sh+4,126→ 22,429 total
Award
Edwards Lifesciences Corp$EW
Common Stock
2024-02-22+8,560→ 43,373.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2024-02-15−27,000→ 0 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2024-02-15$85.62/sh−27,000→ 34,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2024-02-15$36.75/sh+27,000→ 61,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2024-02-13−20,000→ 27,000 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2024-02-13$86.46/sh−20,000→ 34,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2024-02-13$36.75/sh+20,000→ 54,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2023-10-10$36.75/sh+5,000→ 39,813.571 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2023-10-10$72.68/sh−5,000→ 34,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2023-10-10−5,000→ 47,000 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2023-09-08$76.00/sh−5,000→ 34,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2023-09-08$36.75/sh+5,000→ 39,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2023-09-08−5,000→ 52,000 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2023-08-09$36.75/sh+5,000→ 39,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2023-08-09−5,000→ 57,000 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2023-08-09$78.64/sh−5,000→ 34,813.571 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2023-07-10$90.52/sh−5,000→ 34,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2023-07-10$36.75/sh+5,000→ 39,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2023-07-10−5,000→ 62,000 total
Tax Payment
Edwards Lifesciences Corp$EW
Common Stock
2023-07-07$90.46/sh−252→ 34,813.571 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2023-06-13−5,000→ 67,000 total
Exercise/Conversion
Edwards Lifesciences Corp$EW
Common Stock
2023-06-13$36.75/sh+5,000→ 40,055.78 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2023-06-13$85.81/sh−5,000→ 35,055.78 total
Award
Outset Medical, Inc.$OM
Common Stock
2023-05-31+7,681→ 24,596 total
Award
Inari Medical, Inc.
Common Stock
2023-05-18+2,412→ 18,303 total
Award
Edwards Lifesciences Corp$EW
Employee Stock Option (Right to Acquire)
2023-05-11+50,400→ 50,400 total
Award
Edwards Lifesciences Corp$EW
Common Stock
2023-05-11+6,525→ 35,055.78 total
Award
Edwards Lifesciences Corp$EW
Performance Rights
2023-05-11+8,175→ 8,175 total
Sale
Edwards Lifesciences Corp$EW
Common Stock
2023-05-09$88.94/sh−75,600→ 28,530.78 total

Companies

Recent Filings

Address

C/O MASIMO CORPORATION 52 DISCOVERY

IRVINE, CA, 92618

View on SEC.gov